(Q57584479)
Statements
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties (English)
E Schutyser
P Menten
A Wuyts
M Detheux
M Parmentier
S Liekens
P C Maudgal
A Billiau